Search results
Has Arcutis Biotherapeutics (ARQT) Outpaced Other Medical Stocks This Year?
Zacks· 7 days agoFor those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Arcutis Biotherapeutics, Inc. (ARQT Quick QuoteARQT ...
Boston Scientific buys Silk Road Medical for $1.26B
MedTech Dive via Yahoo Finance· 5 days ago“We view this deal as a tuck-in for BSX that will help expand its Peripheral Interventions segment by reaching existing physician call points,” the...
Why Is Silk Road Medical (SILK) Stock Up 24% Today?
InvestorPlace· 5 days agoSilk Road Medical (NASDAQ:SILK) stock is on the rise Tuesday after the medical device company announced an acquisition deal with Boston Scientific (NYSE:...
4 Medical Product Stocks to Buy From a Recovering Industry
Zacks via Yahoo Finance· 4 days agoDespite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting...
Top 7% Medtech Rockets On Boston Sci's $1.16 Billion Buyout
Investor's Business Daily· 5 days agoThe deal focuses on the company's stroke prevention product for patients with carotid artery...
Boston Scientific to buy Silk Road Medical in $1.16 billion deal By Reuters
Investing.com· 5 days agoBoston Scientific to buy Silk Road Medical in $1.16 billion deal
Boston Scientific to Buy Silk Road Medical for About $1.26 Billion
The Wall Street Journal· 5 days agoBoston Scientific has struck a deal to buy medical-device maker Silk Road Medical for about $1.26...
Reasons to Retain The Cooper Companies (COO) in Your Portfolio Now
Zacks· 6 days agoFree Report) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism ...
Silk Road Medical stock rallies on Boston Scientific acquisition deal
Market Watch· 5 days agoSilk Road Medical Inc.’s stock was up 22.6% in pre-market trades on Tuesday after it agreed to be...
Boston Scientific to buy Silk Road Medical in $1.16 billion deal
Reuters· 5 days agoBoston, which generates most of its revenue from sales of heart devices such as pacemakers and stents, will pay $27.50 for each share of Silk Road held, representing a premium of 27% to the ...